Portfolio Composition: BOE


11.53down-0.26 (-2.2053%)

 as of 4:10:00pm ET 01/21/2022

Investment Objective Summary

Under normal market conditions, the Trust will invest at least 80% of its total assets in equity securities or options on equity securities or indices or sectors of equity securities. It may invest in companies located anywhere in the world. It may invest up to 25% of its total assets in equity securities of issuers in emerging countries. Up to 20% of its total assets may be invested in debt securities, including those issued by companies located in emerging markets. Up to 10% of its total assets may be invested in non-investment grade debt securities. Under normal market conditions, it expects to invest in issuers located in approximately 25 countries globally, including the U.S., and in equity issuers in at least three different countries, including the U.S. As part of its investment strategy, it intends to employ a strategy of writing (selling) covered call options on a portion of the common stocks in its portfolio, writing (selling) covered put options and, to a lesser extent, writing (selling) covered call and put options on indices of securities and sectors of securities.

Asset Classification Alternative
Morningstar Category Derivative Income
Total Leverage Ratio 0.00%
Annual Turnover Ratio
AS OF 12/31/2020 reported by fund sponsor
Total Basket Holdings
AS OF 09/30/2021  reported by fund sponsor
Stock Holding (Long) 52 Stock Holding (Short) 138
Bond Holding (Long) 0 Bond Holding (Short) 0

Asset Allocation

AS OF 09/30/2021  reported by fund sponsor
Asset Distribution Type % Long % Short % Net
US Stock
56.41 0.59 55.81
Non US Stock
43.11 0.00 43.11
0.00 0.00 0.00
1.00 0.00 1.00
0.07 0.00 0.07

Top 10 Holdings

AS OF 09/30/2021  reported by fund sponsor
MSFT Microsoft Corp 3.89%
RELX PLC 3.58%
ABBV AbbVie Inc 3.31%
Taiwan Semiconductor Manufacturing Co Ltd 3.3%
Sanofi SA 3.22%
ICE Intercontinental Exchange Inc 3.19%
TXN Texas Instruments Inc 3.19%
TU TELUS Corp 3%
UNH UnitedHealth Group Inc 2.98%
Novo Nordisk A/S Class B 2.84%
Assets in Top 10 Holdings32.49%

Country Exposure

AS OF 09/30/2021  reported by fund sponsor
Country Exposure
United States 56.68%
United Kingdom 17.97%
France 8.69%
Taiwan 3.35%
Canada 3.05%
Denmark 2.88%
China 2.27%
Portugal 1.92%
Spain 1.52%
Singapore 1.12%

Holdings Detail

reported by fund sponsors

Sector Exposure

AS OF 09/30/2021
Sector Exposure
Healthcare 21.65%
Financial Services 19.29%
Technology 18.06%
Consumer Defensive 11.18%
Industrials 11.03%
Communication Services 8.82%
Consumer Cyclical 5.00%
Utilities 2.75%
Real Estate 1.40%
Energy 0.82%

Market Capitalization

AS OF 09/30/2021
Market Capitalization
Large 47.48%
Giant 35.49%
Mid 16.95%
Small 0.08%


AS OF 09/30/2021   More information
Value Blend Growth
CurrentHistoricalCurrent Fund Assets Coverage: 99.52%
Data provided by.

Sectors as of 09/30/2021

Type % Bonds
Government 0.00
Government 0.00
Government Related 0.00
Municipal 0.00
Municipal Taxable 0.00
Municipal Tax-Exempt 0.00
Corporate Bond 0.00
Bank Loan 0.00
Convertible 0.00
Corporate Bond 0.00
Preferred Stock 0.00
Securitized 0.00
Agency Mortgage-Backed 0.00
Non-Agency Residential Mortgage-Backed 0.00
Commercial Mortgage-Backed 0.00
Covered Bond 0.00
Asset-Backed 0.00
Cash & Equivalents 100.00
Cash & Equivalents 100.00
Derivative 0.00
Swap 0.00
Future/Forward 0.00
Option/Warrant 0.00

Duration as of 09/30/2021

Average Duration --
Average Maturity --
Average Coupon % --

Credit Quality as of --

Type % Bonds
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Not Rated --

Maturity as of 09/30/2021

% Bonds

Call Profile as of --

% Bonds
2022 --
2023 --
2024 --
2025 --
2026 --
5 Year + --
Non-Callable --
Before investing in any fund, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for the most recent shareholder report for this information. Read it carefully. Please also review information provided by the fund on its web site.

Top holdings, asset allocation, market sectors, industry exposure, and geographical diversification are as of the date indicated and may not be representative of the fund's current or future investments.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate closed end funds. Criteria and inputs entered, including the choice to make closed end fund comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating closed end funds. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2011 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.